Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

C O N M E D Corp (CNMD)

C O N M E D Corp (CNMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,188,862
  • Shares Outstanding, K 30,968
  • Annual Sales, $ 1,307 M
  • Annual Income, $ 132,420 K
  • EBIT $ 119 M
  • EBITDA $ 196 M
  • 60-Month Beta 0.96
  • Price/Sales 0.84
  • Price/Cash Flow 5.56
  • Price/Book 1.15

Options Overview Details

View History
  • Implied Volatility 45.79% (-5.74%)
  • Historical Volatility 40.20%
  • IV Percentile 34%
  • IV Rank 31.12%
  • IV High 74.17% on 04/11/25
  • IV Low 32.97% on 02/07/25
  • Expected Move (DTE 18) 3.43 (8.95%)
  • Put/Call Vol Ratio 26.00
  • Today's Volume 27
  • Volume Avg (30-Day) 73
  • Put/Call OI Ratio 0.73
  • Today's Open Interest 1,115
  • Open Int (30-Day) 774
  • Expected Range 34.96 to 41.82

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 0.82
  • Number of Estimates 3
  • High Estimate 0.83
  • Low Estimate 0.81
  • Prior Year 0.95
  • Growth Rate Est. (year over year) -13.68%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.37 +8.54%
on 01/29/26
45.69 -15.98%
on 01/08/26
-2.75 (-6.68%)
since 12/30/25
3-Month
35.37 +8.54%
on 01/29/26
46.23 -16.96%
on 11/04/25
-6.10 (-13.71%)
since 10/30/25
52-Week
35.37 +8.54%
on 01/29/26
74.70 -48.61%
on 02/05/25
-32.47 (-45.82%)
since 01/30/25

Most Recent Stories

More News
CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook

CNMD Q4 Deep Dive: Ortho Outperformance and Strategic Refocusing Shape 2026 Outlook

CNMD : 38.39 (+2.89%)
Conmed: Q4 Earnings Snapshot

Conmed: Q4 Earnings Snapshot

CNMD : 38.39 (+2.89%)
CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars

CONMED (NYSE:CNMD) Beats Q4 CY2025 Sales Expectations, Stock Soars

CNMD : 38.39 (+2.89%)
CONMED Corporation Announces Fourth Quarter and Full-Year 2025 Financial Results

CONMED Corporation (NYSE: CNMD) today announced financial results for the fourth quarter and full-year ended December 31, 2025. Fourth Quarter 2025 Highlights ...

CNMD : 38.39 (+2.89%)
CONMED Earnings: What To Look For From CNMD

CONMED Earnings: What To Look For From CNMD

CNMD : 38.39 (+2.89%)
Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)

Surgical Equipment & Consumables - Diversified Stocks Q3 Results: Benchmarking CONMED (NYSE:CNMD)

CNMD : 38.39 (+2.89%)
3 Reasons to Sell CNMD and 1 Stock to Buy Instead

3 Reasons to Sell CNMD and 1 Stock to Buy Instead

CNMD : 38.39 (+2.89%)
3 Reasons to Avoid CNMD and 1 Stock to Buy Instead

3 Reasons to Avoid CNMD and 1 Stock to Buy Instead

CNMD : 38.39 (+2.89%)
CONMED Corporation Announces Chief Financial Officer Transition

Todd Garner to step down as CONMED’s CFO, effective March 15, 2026, and remain In an Advisory Role Through November 2, 2026 Company Initiates Comprehensive...

CNMD : 38.39 (+2.89%)
CONMED Corporation to Present at the 44th Annual J.P. Morgan Healthcare Conference

CONMED Corporation (NYSE: CNMD) today announced that Patrick J. Beyer, President and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will present...

CNMD : 38.39 (+2.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered...

See More

Key Turning Points

3rd Resistance Point 41.09
2nd Resistance Point 39.77
1st Resistance Point 39.08
Last Price 38.39
1st Support Level 37.07
2nd Support Level 35.75
3rd Support Level 35.06

See More

52-Week High 74.70
Fibonacci 61.8% 59.68
Fibonacci 50% 55.03
Fibonacci 38.2% 50.39
Last Price 38.39
52-Week Low 35.37

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar